Astellas Pharma Inc (ALPMF) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

FY2025 First Quarter Financial Results Announcement Meeting organized by ASTEDASH Pharma Inc. I have a very busy schedule today. I'm serving as a facilitator today. I'm Chief Communications and IR Officer. Ikeda, thank you for your time. After our presentation, we will move on to the Q&A session. We will present based on the presentation material posted on the website under IR Meetings. Including Q&A session, we have simultaneous translation between Japanese and English. We cannot guarantee the accuracy of simultaneous translation. Thank you for understanding. You can choose the language from the Zoom webinar screen menu. If you select the original sound, you can listen to the original sound without going through the simultaneous translation. This is a disclaimer today. This material, oral presentation by representatives for the company and answers and statements by representatives for the company in the current session includes forward-looking statements based on assumptions and beliefs in light of information currently available to management and subject to significant risks and uncertainties. Actual financial results may differ materially depending on a number of factors. They contain information on former protocols including compliance under development, but this information is not intended to make any representations or advertisements regarding the efficacy or effectiveness of these preparations, promote unapproved uses in any fashion, nor provide medical advice of any kind to its participants. CFO Atsushi Kitamura CRO Tadaoki Tanibuchi Chief Commercial and Medical Affairs Officer Klaus Zieder We have three members from our company. So we'd like to go into a presentation. Kitamura-san, please. Hello, everyone. I'm Atsushi Kitamura from Estella Pharma, Inc. Thank...